July 30, 2009, Princeton, NJ
The Medicines and Healthcare products Regulatory Agency (MHRA) awarded Covance's (Princeton, NJ) clinical research unit in Leeds, UK, where the company conducts first-in-human studies, with standard and supplementary accreditation for the conduct of clinical pharmacology in Europe. The MHRA accreditation, which is voluntary, ensures that research facilities and studies meet industry standards for patient safety in early clinical development.
"Covance delivers the highest level of data quality and safety for first-in-human trials, which is confirmed by the accreditation," said Rob Aspbury, MD, Covance's managing director of clinical research services, in a press release.
In order to receive this type of accreditation, formal inspections are performed by MHRA, which is based in London.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.